LY-518674

DB12988InvestigationalSmall molecule

LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor alpha
Curator reviewed
Formula / weight: C₂₃H₂₇N₃O₄ · 409.486 g/mol (avg)
Code names: KB-68984 · LY-518674 · LY-674

Resolves to

Compound

Structure

InChIKeyPNHFDVSKDSLUFH-UHFFFAOYSA-NSMILESCC1=CC=C(CN2N=C(CCCC3=CC=C(OC(C)(C)C(O)=O)C=C3)NC2=O)C=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with LY-518674, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.